RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC.

QQQ $ 454.82 $ -0.84 (-0.19 %)

DIA $ 398.57 $ 6.05 (1.59 %)

SPY $ 530.36 $ 4.76 (0.91 %)

TLT $ 91.26 $ 0.61 (0.68 %)

GLD $ 225.37 $ -1.27 (-0.59 %)

Previous Close

$ 1.37

Open

$ 1.38

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.36 - $ 1.38

52 Week Range

$ 1.21 - $ 8.00

Volume

91,689

Average Volume

Market Cap

38.25M

Beta (5Y Monthly)

$ -0.05

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	04-15-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-30-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-15-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	03-15-2022	12-31-2021	10-K
11	11-15-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-17-2021	03-31-2021	10-Q
14	03-22-2021	12-31-2020	10-K
15	01-14-2021	11-30-2020	10-Q
16	10-14-2020	08-31-2020	10-Q
17	07-07-2020	05-31-2020	10-Q
18	05-04-2020	02-29-2020	10-K
19	01-10-2020	11-30-2019	10-Q
20	10-08-2019	08-31-2019	10-Q
21	07-03-2019	05-31-2019	10-Q
22	05-22-2019	02-28-2019	10-K
23	01-09-2019	11-30-2018	10-Q
24	10-11-2018	08-31-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Benchmark Reiterates Speculative Buy on Re...
05/28/2024 12:22:12

Benchmark analyst Bruce Jackson reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Speculative Buy and maintains $17 pri...

Reviva Announces $3M Registered Direct Off...
05/28/2024 12:01:49

Reviva Provides Enrollment Update For Its ...
05/15/2024 12:03:17

– 358 enrolled and 223 patients currently on treatment across sites in the USA, Europe and Asia –– Brilaroxazine is generally w...

Reviva Pharmaceuticals Q1 EPS $(0.25) Beat...
05/14/2024 12:29:08

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate o...

Reviva To Present New Preclinical Efficacy...
05/13/2024 12:06:11

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical co...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
05/09/2024 16:31:09

HC Wainwright & Co. Reiterates Buy on Revi...
04/22/2024 10:15:41

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

Benchmark Reiterates Speculative Buy on Re...
04/16/2024 13:59:36

Benchmark analyst Bruce Jackson reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Speculative Buy and maintains $17 pri...

Reviva Pharmaceuticals Q4 EPS $(0.35) Miss...
04/15/2024 12:49:57

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate...

Reviva Announces Alignment With FDA On Bri...
04/15/2024 12:33:26

Reviva To Present RECOVER Phase 3 Clinical...
03/28/2024 12:07:47

Reviva to Present RECOVER Phase 3 Clinical...
03/26/2024 12:12:57

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical co...

HC Wainwright & Co. Reiterates Buy on Revi...
03/25/2024 10:30:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

HC Wainwright & Co. Reiterates Buy on Revi...
02/20/2024 12:19:40

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

Reviva to Host KOL Event To Discuss Toplin...
02/06/2024 13:13:26

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical co...

Reviva Provides Corporate And Program Upda...
01/04/2024 13:35:37

– Schizophrenia late-stage clinical program advances with positive topline Phase 3 data, successful ongoing enrollment in open ...

HC Wainwright & Co. Reiterates Buy on Revi...
12/26/2023 11:16:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains ...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
12/22/2023 13:07:08

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
12/18/2023 21:31:50

Reviva Announces $30M Registered Direct Of...
11/16/2023 13:01:53